Marin Software (MRIN) has had the highest return since January 1, 2025 by a US stock with a market cap of <= $1B, returning 155,305.4%.
| ASSET | % RETURN |
|---|---|
Marin Software (MRIN) | 155,305.41% |
DeFi Development (DFDV) | 2,551.21% |
Oncology Institute (TOI) | 1,243.14% |
Zepp Health (ZEPP) | 1,216.92% |
SRM Entertainment, Inc Common Stock (SRM) | 1,046.2% |
CannBioRx Life Sciences (ATNFW) | 986.73% |
Kindly (NAKA) | 794.35% |
Global Interactive Technologies (GITS) | 779.67% |
Kindly MD, Inc Common Stock (KDLY) | 779.03% |
Imunon (IMNN) | 732.42% |
Asset Entities Inc Class B Common Stock (ASST) | 726% |
mF International Limited Ordinary Shares (MFI) | 710.7% |
Lixte Biotechnology (LIXTW) | 621.43% |
Dominari (DOMH) | 608.29% |
Quantum BioPharma (QNTM) | 540.26% |
Abits (ABTS) | 531.58% |
So-Young International (SY) | 514.23% |
Airnet Technology (ANTE) | 485.65% |
180 Life Sciences (ATNF) | 472.07% |
Junee Limited Ordinary Shares (JUNE) | 465.35% |
Arena (AREN) | 405.8% |
ABVC BioPharma (ABVC) | 398.31% |
Immunoprecise Antibodies (IPA) | 392.68% |
Vigil Neuroscience (VIGL) | 373.53% |
VivoPower International (VVPR) | 369.63% |
